| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |